Site Reference ID/Investigator# 13324 — Tulsa, Oklahoma

Site Reference ID/Investigator# 13324 is a clinical research site located in Tulsa, Oklahoma, United States 74135.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Site Reference ID/Investigator# 13324 has participated in 1 clinical trials.

Therapeutic areas: Precocious, Leuprolide Acetate, Luteinizing Hormone (LH).

Sponsors: AbbVie (prior sponsor, Abbott).

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site Reference ID/Investigator# 13324?

Site Reference ID/Investigator# 13324 has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site Reference ID/Investigator# 13324 conducted?

Site Reference ID/Investigator# 13324 has 1 clinical trials on record. Their work covers Precocious, Leuprolide Acetate, Luteinizing Hormone (LH).

Is Site Reference ID/Investigator# 13324 accredited by Crixeo Health?

Site Reference ID/Investigator# 13324 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site Reference ID/Investigator# 13324?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.